Literature DB >> 23683506

Cutaneous squamous cell carcinoma: defining the high-risk variant.

A Martorell-Calatayud1, O Sanmartín Jimenez, J Cruz Mojarrieta, C Guillén Barona.   

Abstract

With a lifetime incidence of approximately 10% in the general population, cutaneous squamous cell carcinoma (CSCC) is the second most common type of nonmelanoma skin cancer. Most CSCCs are benign and can be completely eradicated by surgery or other dermatological procedures. There is, however, a subgroup associated with an increased likelihood of lymph node metastases and, therefore, with high morbidity and mortality. This article analyzes the various factors that define aggressive CSCC. We propose a method for defining high-risk SCC on the basis of a series of major and minor criteria. This method will allow better prognostic evaluation and enable personalized management of patients with high-risk SCC, possibly leading to improved overall survival.
Copyright © 2011 Elsevier España, S.L. and AEDV. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23683506     DOI: 10.1016/j.adengl.2011.12.012

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  14 in total

1.  Rare association of cystic squamous cell carcinoma and small lymphocytic B cell lymphoma: successful surgical approach.

Authors:  Uwe Wollina; Jacqueline Schönlebe; Birgit Heinig; Andreas Nowak; Anastasiya Atanasova Chokoeva; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2016-09-08

Review 2.  Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and Survival: An Exponential Growth Model.

Authors:  A Tejera-Vaquerizo; J Cañueto; A Toll; J Santos-Juanes; A Jaka; C Ferrandiz; O Sanmartín; S Ribero; D Moreno-Ramírez; F Almazán; M J Fuente; S Podlipnik; E Nagore
Journal:  Actas Dermosifiliogr       Date:  2020-09-20

Review 3.  Radiotherapy in the Adjuvant and Advanced Setting of CSCC.

Authors:  Paolo Muto; Francesco Pastore
Journal:  Dermatol Pract Concept       Date:  2021-10-01

Review 4.  Management of High-Risk Squamous Cell Carcinoma of the Skin.

Authors:  Teresa Fu; Sumaira Z Aasi; S Tyler Hollmig
Journal:  Curr Treat Options Oncol       Date:  2016-07

Review 5.  Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer.

Authors:  Silvia Rocío Lucena; Nerea Salazar; Tamara Gracia-Cazaña; Alicia Zamarrón; Salvador González; Ángeles Juarranz; Yolanda Gilaberte
Journal:  Int J Mol Sci       Date:  2015-10-28       Impact factor: 5.923

6.  Advances and Applications of Ion Torrent Personal Genome Machine in Cutaneous Squamous Cell Carcinoma Reveal Novel Gene Mutations.

Authors:  Yu-Ping Hsiao; Chun-Te Lu; Ju Chang-Chien; Wan-Ru Chao; Jiann-Jou Yang
Journal:  Materials (Basel)       Date:  2016-06-14       Impact factor: 3.623

Review 7.  A Review of the Literature of Surgical and Nonsurgical Treatments of Invasive Squamous Cells Carcinoma.

Authors:  Concetta Potenza; Nicoletta Bernardini; Veronica Balduzzi; Luigi Losco; Alessandra Mambrin; Anna Marchesiello; Ersilia Tolino; Sara Zuber; Nevena Skroza; Ilaria Proietti
Journal:  Biomed Res Int       Date:  2018-04-02       Impact factor: 3.411

8.  Expression of nuclear survivin in normal skin and squamous cell carcinoma: a possible role in tumour invasion.

Authors:  K Dallaglio; T Petrachi; A Marconi; F Truzzi; R Lotti; A Saltari; P Morandi; M Puviani; A Maiorana; C Pincelli
Journal:  Br J Cancer       Date:  2013-11-05       Impact factor: 7.640

Review 9.  Advances in the management of cutaneous squamous cell carcinoma.

Authors:  Sonal A Parikh; Vishal A Patel; Desiree Ratner
Journal:  F1000Prime Rep       Date:  2014-08-01

10.  Over-Expression of CD200 Predicts Poor Prognosis in Cutaneous Squamous Cell Carcinoma.

Authors:  Li Li; YanLi Tian; ChengFang Shi; Hua Zhang; Zhi Zhou
Journal:  Med Sci Monit       Date:  2016-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.